Concerto Versa
Payments companies reported to CMS as associated with Concerto Versa. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Concerto Versa, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Concerto Versa
These are the largest totals companies reported as associated with Concerto Versa. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rahul Patel | New York, NY | Vascular & Interventional Radiology | $9,021.67 |
| Ripal Gandhi | Miami, FL | Vascular & Interventional Radiology | $6,819.36 |
| Melhem Ghaleb | El Paso, TX | Vascular & Interventional Radiology | $3,260.01 |
| Clifford Weiss | Baltimore, MD | Diagnostic Radiology | $2,954.23 |
| Jafar Golzarian | Golden Valley, MN | Vascular & Interventional Radiology | $2,278.60 |
| Gloria Salazar | Chapel Hill, NC | Vascular & Interventional Radiology | $1,801.21 |
| Anuj Malhotra | Albany, NY | Vascular & Interventional Radiology | $1,572.35 |
| Bulent Arslan | Chicago, IL | Vascular & Interventional Radiology | $1,369.38 |
| Dania Daye | Framingham, MA | Vascular & Interventional Radiology | $1,282.46 |
| Suvranu Ganguli | Boston, MA | Vascular & Interventional Radiology | $1,098.60 |
Prescribed Concerto Versa?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.